New York, New York - July 16, 2012 (Investorideas.com Newswire) Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for Alnylam Pharmaceuticals, Inc. (NasdaqGS :ALNY), trading at $16.05, up $3.53 or 28.19%) as of 11:04AM EDT on over 2 Million shares. As of the time of this report, ALNY was the top percentage gainer on the NASDAQ.

New York, New York - July 11, 2012 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a snapshot of recent news from biopharma stocks reporting developments for the treatment of lung cancer. Sunshine Biopharma Inc. (OTCBB: SBFM) reported news on its lead compound, Adva-27a and OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced an update on its lead product, custirsen.

New York, New York - July 10, 2012 (Investorideas.com Newswire) Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for BioMimetic Therapeutics Inc. (NasdaqGS :BMTI), trading at $3.38, up $ 0.58 (20.72%) 11:33AM on over 1 Million shares, making it the morning top percentage gainer on NASDAQ. The stock has a morning high of $3.56.

New York, New York - July 5, 2012 (Investorideas.com Newswire, Biotechindustrystocks.com) Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for Sunshine Biopharma Inc. (OTCBB: SBFM). The stock is trading at $0.41, up $ 0.09 or (28.13%) on 247,000 shares.